The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 110.50
Bid: 109.50
Ask: 110.50
Change: 1.00 (0.91%)
Spread: 1.00 (0.913%)
Open: 110.00
High: 112.00
Low: 109.50
Prev. Close: 109.50
MCB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of European Personal Care liquids

3 Jul 2018 07:00

RNS Number : 3461T
McBride PLC
03 July 2018
 

3 July 2018

 

McBride plc

 

Sale of European Personal Care liquids

 

McBride plc, the leading European manufacturer and supplier of Co-manufactured and Private Label products for the Household and Personal Care market, today announces that it has agreed to sell its European personal care liquids business to Royal Sanders Group for a cash consideration of £12.5m.

 

In its half year results of 22 February 2018, McBride announced plans to launch an accelerated transformation programme to return its Personal Care & Aerosols (PCA) division to break even within 18 months. Since February, the Group has announced proposals to close it UK aerosols operations at Hull. As a result of this action and the absorption of certain volumes into our French aerosols operation, the Group expects its ongoing aerosols operation to be at break-even profitability levels by July 2019.

 

As the next step in the PCA transformation programme, the Group today announces that it has agreed terms with Royal Sanders for the disposal of the Group's European Personal Care liquids activities, which comprises two manufacturing sites at Bradford, UK and Ieper, Belgium, which supply customers with a range of personal hygiene, haircare and oral care products.

 

The proposed transaction, which is subject to customary closing conditions, will comprise the disposal of the trade and assets of the Group's European personal care liquids business for a cash consideration of £12.5m (subject to any post-closing working capital adjustments), payable on completion. In the 12 months to June 2017 the business generated revenues of £58.8m and an EBITA loss of £1.9m. Gross assets at 31 December 2017 were £19.8m. For the 12 months to 30 June 2018, the business is expected to generate revenues of £56.0m and an EBITA loss of £2.8m. Proceeds of the sale will be used to pay down Group net debt and settle transaction costs. The transaction is expected to complete during the last quarter of 2018.

 

 

Rik De Vos, Group Chief Executive, commented;

 

"The agreement to sell our European Personal Care liquids activities follows a comprehensive review of the business and marks the final element in the transformation plan for our European PCA activities. The transaction enables the business to be developed as part of a dedicated personal care manufacturer of greater scale and positions McBride's European operations as a focused Household business with a clear strategy to deliver sustainable profitable growth." 

 

 

For further information please contact:

 

McBride plc

Rik De Vos, Chief Executive Officer

0161 203 7570

Chris Smith, Chief Financial Officer

0161 203 7570

FTI Consulting

020 3727 1017

Ed Bridges, Nick Hasell

 

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation which came into effect on 3 July 2016.

 

-Ends-

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DISEAAXAEEKPEAF
Date   Source Headline
3rd Dec 20184:15 pmRNSIssue of B Shares
19th Nov 20187:00 amRNSCompletion of Disposal
31st Oct 20182:40 pmRNSHolding(s) in Company
24th Oct 20184:21 pmRNSResult of AGM
23rd Oct 20187:00 amRNSAGM Trading Update
16th Oct 201812:52 pmRNSHolding(s) in Company
16th Oct 201812:51 pmRNSHolding(s) in Company
12th Oct 20184:48 pmRNSHolding(s) in Company
21st Sep 20183:59 pmRNSAnnual Financial Report and Notice of AGM
14th Sep 20184:09 pmRNSTotal Voting Rights
13th Sep 20185:01 pmRNSDirector/PDMR Shareholding
12th Sep 20184:33 pmRNSNotification and public disclosure of LTIP
12th Sep 20183:49 pmRNSHolding(s) in Company
6th Sep 20187:00 amRNSFinal Results
13th Aug 20184:20 pmRNSHolding(s) in Company
7th Aug 20181:24 pmRNSHolding(s) in Company
3rd Aug 20182:03 pmRNSHolding(s) in Company
10th Jul 20189:12 amRNSHolding(s) in Company
6th Jul 20183:42 pmRNSHolding(s) in Company
3rd Jul 20187:00 amRNSTrading Update
3rd Jul 20187:00 amRNSSale of European Personal Care liquids
5th Jun 20185:10 pmRNSHolding(s) in Company
5th Jun 201810:24 amRNSIssue of Equity
27th Apr 201812:45 pmRNSHolding(s) in Company
15th Mar 20185:33 pmRNSTR1 - Notification of Major Holdings
12th Mar 20184:54 pmRNSNotification of Major Holdings
2nd Mar 20183:27 pmRNSNotification of Major Holdings
27th Feb 20185:02 pmRNSTotal Voting Rights
27th Feb 20185:02 pmRNSNotification and public disclosure of LTIP
22nd Feb 20187:00 amRNSHalf-year Report
13th Feb 20184:52 pmRNSHolding(s) in Company
11th Jan 20183:50 pmRNSHolding(s) in Company
8th Jan 20187:00 amRNSTrading Update
4th Dec 20174:55 pmRNSIssue of B Shares
16th Nov 201710:40 amRNSHolding(s) in Company
13th Nov 20179:12 amRNSHolding(s) in Company
10th Nov 201710:31 amRNSHolding(s) in Company
25th Oct 20174:35 pmRNSResult of AGM
24th Oct 20177:00 amRNSAGM Trading Update
3rd Oct 20172:30 pmRNSInvestor Day and Site Visits
29th Sep 201712:00 pmRNSCompletion of the acquisition of Danlind a/s
22nd Sep 20174:11 pmRNSAnnual Report and Accounts
22nd Sep 20171:43 pmRNSHolding(s) in Company
13th Sep 20174:00 pmRNSHolding(s) in Company
13th Sep 20172:30 pmRNSDirector/PDMR Shareholding
12th Sep 20174:27 pmRNSDirector/PDMR Shareholding
7th Sep 20177:00 amRNSFinal Results
4th Sep 20177:00 amRNSAcquisition of Danlind a/s
31st Aug 20174:04 pmRNSDirectorate Change
18th Aug 201710:37 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.